Chlamydia Infection Diagnostics and Therapeutics Market Will Expand at a Robust CAGR of 6.0% Between 2017 - 2025
The global chlamydia infection diagnostics and therapeutics market is fairly consolidated as the combined share of the top five vendors in the diagnostics segment exceeded 58% of the overall market while the leading companies in the therapeutics segment accounted a share for approximately 24% in 2016, Transparency Market Research (TMR). Despite the presence of several players, the global market features a low competitive rivalry among the players. A growing number of products approved by governmental regulatory agencies in various developing...
View full press release